This review highlights key advancements in understanding how lipid metabolism and complement dysregulation contribute to Age-related Macular Degeneration (AMD). Emerging evidence supports a dual-targeted therapeutic approach combining lipid modulators with complement inhibitors to improve patient outcomes.
.png)
Source : https://pubmed.ncbi.nlm.nih.gov/38397362/
Familial hypercholesterolemia is a genetically determined disease characterized by elevated plasma total and LDL cholesterol levels from the very first years of life, leading to early atherosclerosis. Nutritional intervention is...
This review examines nutritional interventions and nutraceuticals for treating dyslipidemia in childhood, focusing on lipid-lowering supplements, their mechanisms, and the benefits and risks in pediatric patients with severe dyslipidemia.
Source : https://pubmed.ncbi.nlm.nih.gov/38363694/
Children with familial hypercholesterolemia benefit from early detection and optimal treatment of their elevated LDL-C levels.
Early detection and optimal lipid-lowering therapy in children with familial hypercholesterolemia reduce the risk of premature atherosclerotic cardiovascular disease, with novel treatments improving outcomes and cost-effectiveness.